GC
AH

GMT Capital’s Accretive Health AH Stock Holding History

GMT Capital’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-894,200
Closed -$2.01M – 163
2016
Q4 		$2.01M Sell
894,200
-217,600
-20% -$490K 0.04% 106
2016
Q3 		$2.71M Hold
1,111,800
– – 0.06% 106
2016
Q2 		$2.22M Hold
1,111,800
– – 0.05% 103
2016
Q1 		$2.83M Buy
+1,111,800
New +$2.83M 0.07% 88
2015
Q4 		– Sell
-1,122,700
Closed -$3.05M – 138
2015
Q3 		$3.05M Buy
1,122,700
+378,672
+51% +$1.03M 0.08% 90
2015
Q2 		$4.09M Buy
+744,028
New +$4.09M 0.11% 74
2013
Q4 		– Sell
-807,177
Closed -$7.36M – 105
2013
Q3 		$7.36M Buy
807,177
+67,162
+9% +$668K 0.17% 57
2013
Q2 		$8M Buy
+740,015
New +$7.79M 0.18% 60

GMT Capital's AH Position: Q1 2017 in Review

GMT Capital sold out of Accretive Health (AH) in Q1 2017, closing a stake of 894,200 shares — an estimated $2.01M sold.

GMT Capital first reported a position in AH in Q2 2013 and held it in 8 quarters. The position peaked at $8M in Q2 2013. 0 funds tracked by Wall St. Rank hold AH as of Q1 2017.

  • GMT Capital reported no remaining Accretive Health position as of Q1 2017 after selling out during the quarter.
  • GMT Capital sold 894,200 Accretive Health shares in Q1 2017, an estimated $2.01M.
  • GMT Capital first reported a position in Accretive Health in Q2 2013 and held it in 8 quarters.
  • GMT Capital's Accretive Health position peaked at $8M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Accretive Health as of Q1 2017.

Based on GMT Capital's 13F filing for Q1 2017, filed 12 May 2017.